{"name":"Nanjing Legend Biotech Co.","slug":"nanjing-legend-biotech-co","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPLXN4bElrVmUzZm9ocjlkUEc4LWt3YlZzTE8zZXJ3NDRQczllSFdhczdLcG96MXZISzRRS0tDZmNaa1dZd3dEc3FrTVlyV1l3T3FhNXIyeGxTOVVyUVp3bjQtNnROVkFPVTBzZldOTnNocE1OSUVlbEZJcWRMMGJZY1JuVmI5dDc1S3VCek9XZkZUdXVSeW44aWVzY1dsa2xOZUtkVmRVeWZKMzVK?oc=5","date":"2025-07-09","type":"pipeline","source":"Reuters","summary":"Exclusive: US lawmakers renew concerns about GenScript's ties to China - Reuters","headline":"Exclusive: US lawmakers renew concerns about GenScript's ties to China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE93azBiNmRvTXFBblhvSGt6emFjS0lrb0RBRDM4aTgzQjJaQnA2S3hPREFqRDVOYThnd2wwRVJYVEFVTVV6V1hRT0dIU0pWeVEwTUVYZHY5SU5pMnNzaFptX1l4V1hmUEdYM0E?oc=5","date":"2025-06-09","type":"pipeline","source":"ChinaTalk | Jordan Schneider","summary":"Biotech - ChinaTalk | Jordan Schneider","headline":"Biotech - ChinaTalk | Jordan Schneider","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNOXcyek5vakItWXNwTWFOdFM3OEhGZmJieFYxLWl4dDRmNnlaNGN4cXZxM2VyRjMzUnBKa1dobmdmbnZIekUxR2F5eFpiQmRicGcwTlMyUVN3Zkk4aHBFYWM0ZnZnNUg0XzZTNktyeFQ1SUw3cmx0VldjdjhGeUwzNk5FNlVFekUxb0cxdUNrUVBaS3FLc1Ixa0lIZmRqRG83VlpPdWlBVk9fN1NhZzBFMlgzWkQxN01hMkhfM094d3hWSG9nOW1BMFlJQUk2TlJjbjZiN1U2NXhEU19HdXRveDNNdGp0S08yRlUzVDZNQ1VQUHpONmNNazhtcjI?oc=5","date":"2025-03-24","type":"pipeline","source":"PR Newswire","summary":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight - PR Newswire","headline":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQU3NGRzVaZ0hmY0xkbmh0OGlZZm1WTjc3X1hIWkd4aU9zbTlFbmd2ZndKR2FvY1h0Z1lXUmFRZ3QtdC1jYmhRWEVjQWk3SzVwLTE1YjgzS3dYVF9ZTlQ1R1JFWlB0RWpsT2VFbWJTdk9QNUs2VlVCYUJxSU9Bd0NiaUktNVVNYXl0VlE?oc=5","date":"2025-01-09","type":"pipeline","source":"Fierce Pharma","summary":"With BIOSECURE in limbo, should BeiGene or Legend sell itself in 2025? Analysts weigh in - Fierce Pharma","headline":"With BIOSECURE in limbo, should BeiGene or Legend sell itself in 2025? Analysts weigh in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE13MktGVVRhQmtaTGoyVHZRQ2ZTaXpHb3A2V1hhNXA3X01UdFZiU0JmN09JV1BzYlZWV25IMl95MlVlU3dQeG9aQ0VZN3FLX2hsd01IOUloemZMcFZCeUVmSmtwTTdZWld0QkhxMEdXdlo4OEN3ZmZjWEVzbw?oc=5","date":"2024-10-07","type":"pipeline","source":"statnews.com","summary":"12 people changing the course of the Chinese biopharma industry - statnews.com","headline":"12 people changing the course of the Chinese biopharma industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5nN0UwZFN6SS00YWR3UUd6SkxjRHJTdjJqUi1XdmhLbS1CMmlkckFmWjFTRmhkQXRBWVBOdkpyVHowd1Zxem1QbVU5czBRLUNnTVZIMGFhVlRZa0pVY2ZJQlVhWEh2bGk1ZjBXNERFNEpveF94LWlz0gF8QVVfeXFMT0p4dzQ4bXFoMlhaLTBIMFJzVFhpS3FhQmpBX29fSThZZk9hT2hWSlZ2X2xJSDNsTjhZRXJ3bUF3Uk52NWhvUWlhbmVkRGdKTEJnSnJLdUdPY3V3R3FXMXNmbk1UM253d0k4TEN0X2lfb2VfbjJuYzJaZjFVNA?oc=5","date":"2024-08-18","type":"pipeline","source":"BioInformant","summary":"Is the CAR-T Cell Therapy Craze Driving Pharma Investment? - BioInformant","headline":"Is the CAR-T Cell Therapy Craze Driving Pharma Investment?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPM1JLV0Nwcl9CWFV5Nm52Q1p4am9MN3V0dVY4X0s4T3p1a3d2OVBmdWQ2eVVjUXZwbjdZQkluZXlHelVNazNuWmlWMEJiM29fajdVQnBRTlAzTTAzVkVUTjBXbjlLNk9hMkE5NDFBNEI3aURMYm5ZTWpaOWo5cFJ1ZVVrZlRjeFRZOFV0X0lTYXdPemJXWWFjUGVYU2JRSm1XaXhPdXI0Qy1qYVE?oc=5","date":"2024-07-16","type":"pipeline","source":"BioProcess International","summary":"Legend Bio said to have received takeover bid; Stock price climbs - BioProcess International","headline":"Legend Bio said to have received takeover bid; Stock price climbs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPYllwVzFjTGZGajlmemVneFlhWGgxWkNXVk9LcmNabXhrNFpFV3VpRGhqTFAyd1kwbjF4SnM2WTlsamVjdDBnZFR1ZmN3M3RKUDNLVGRVNnplN2JYTEVoWnh4YWYtS2lCWHF2MUl2YVlGMGFqb1NVckpsSzRBeC1BTkJhUW1fZnpZVy1TMEhCN2FObHBWcVZQcWNBLVl0NktWZnZiakpKbVhKY3Z5RUdNbmhzTi1HZThiSEEwYnlzQTFwVmdTS3E1YW9zWjFEZw?oc=5","date":"2024-05-14","type":"earnings","source":"Yicai Global","summary":"Legend Biotech’s Losses Narrow in First Quarter; Chinese Pharma Firm Says It Should Break Even by 2026 - Yicai Global","headline":"Legend Biotech’s Losses Narrow in First Quarter; Chinese Pharma Firm Says It Should Break Even by 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQTHl5N1EyVnBuVmhXay15RUxSV0lkbHBKWFV5a1g0azZYTEhYV1prLWFLaHhBWUtuZU1DZV81a3ZnRDgtOVRURkhKZHRFalcwTTgwS0dzbTBkbVhKcC1XeWY4WTJnUUlxN1NRTzFTS2xQSWpnRk4tSkVsVmV4Z3lHb3RwNnQ3Qlc1ejRfbVB1MGlrcGpYV1Q2dWxaVkNncm1XOU5UWEhybHpQUmxm?oc=5","date":"2024-04-30","type":"trial","source":"BioWorld News","summary":"China’s investigator trials accelerate competitive CAR T development - BioWorld News","headline":"China’s investigator trials accelerate competitive CAR T development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQUmFDbmhRUjktUTUzblhMZWplVVNXLUdHZVVWVVZHbUJyNElyMVFKVVB5M0FFeG5JWXZ2YzVQTW52LXBGd3BiTnhPUEkzYXNHMnFyQ1A3ZzBzd3VjaE1pVWRfUVFBR0FjRzlsa0JaVEpuamoycTJWY1NzVnZqU2JOM3hVcXpDN0lrcGlKMU1aNk01clVLeXdUMXhqUWJXT01nLWc?oc=5","date":"2023-07-23","type":"pipeline","source":"The Wire China","summary":"The Biotech Urban Legend - The Wire China","headline":"The Biotech Urban Legend","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPb0xKOVpGc1ZnZHAwbnNoUjRLWF9RMEJrNjRvdnQ5Ym1WUlpKb1JENWxEaDc4TGFlVW5FRXRqVDZ2RzY1NUtRWU54cDhCdjlUOENpcEswZVZEMkd4TGE4bllwTVZwTjl3aUdJbVUxdmFMaGxRWnphMTlETHl3MEphQVlOVmpLaVA0VkdWUw?oc=5","date":"2020-06-05","type":"trial","source":"BioPharma Dive","summary":"Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech’s biggest IPO of 2020 - BioPharma Dive","headline":"Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech’s biggest IPO of 2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNTXFIanRSNzlJMzM0dnBXNnFaTHR5UVh3M1NURTlXNU9zLVU4MWM3akRSd2I1TWdMVEFQbEFGbUMtYi1WS0UxTUdwczhiNHRMWmZtYmRxSkZOdkxuczJxWUtINzl0R0RZSnIxaTh1dnJ2N2w5WkdldTI5SVZabXRyZXFfdE5UODlkM29qaUg1aHFjaFp6TzRtNFljN3JUWk5KdFE?oc=5","date":"2017-12-22","type":"deal","source":"Fierce Biotech","summary":"After impressing at ASCO, Legend gains Johnson & Johnson as new CAR-T partner - Fierce Biotech","headline":"After impressing at ASCO, Legend gains Johnson & Johnson as new CAR-T partner","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}